skip to content

Centre for Law, Medicine and Life Sciences

Faculty of Law
 
Read more at: American Journal of Public Health publishes article co-authored by Prof. Kathy Liddell on governing global antimicrobial resistance

American Journal of Public Health publishes article co-authored by Prof. Kathy Liddell on governing global antimicrobial resistance

23 March 2022

The American Journal of Public Health has published an article co-authored by Prof. Kathy Liddell (Director of LML) on governing global antimicrobial resistance. Antimicrobial resistance (AMR) is among the most urgent global health challenges of our time. AMR can develop with each use of an antimicrobial, regardless of the...


Read more at: Nature Biotechnology accepts paper from LML on European Patent Protection for Medical Uses of Known Products and Drug Repurposing

Nature Biotechnology accepts paper from LML on European Patent Protection for Medical Uses of Known Products and Drug Repurposing

27 January 2022

Nature Biotechnology has accepted an eighth article from LML’s empirical-based IP research group. Drug repurposing is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indications. Finding new therapeutic uses for existing medicines holds...


Read more at: Dr Stephanie Palmer and Dr Stevie Martin appointed as General Editors of European Human Rights Law Review

Dr Stephanie Palmer and Dr Stevie Martin appointed as General Editors of European Human Rights Law Review

19 January 2022

Two members of LML, Dr Stephanie Palmer and Dr Stevie Martin have been appointed (alongside Dr Kirsty Hughes ) as the General Editors of the European Human Rights Law Review (EHRLR) . The EHRLR is the leading human rights law journal providing unrivalled, cutting-edge coverage of key issues in human rights law. It is at...


Read more at: Medical Law Review publishes article by LML team on negligent standards of care in diagnosis

Medical Law Review publishes article by LML team on negligent standards of care in diagnosis

14 January 2022

Diagnosis lies at the heart of the medical encounter, yet it has received much less attention in legal literature than treatment. Though it is widely assumed that negligent diagnosis claims should be governed by the Bolam test, the article ‘Differentiating Negligent Standards of Care in Diagnosis’ argues that this is not...


Read more at: Medical Law Review publishes LML article on negligent standards of care in diagnosis

Medical Law Review publishes LML article on negligent standards of care in diagnosis

13 January 2022

Diagnosis lies at the heart of the medical encounter, yet it has received much less attention in legal literature than treatment. Though it is widely assumed that negligent diagnosis claims should be governed by the Bolam test, ‘Differentiating Negligent Standards of Care in Diagnosis’ argues that this is not always the...


Read more at: Nature Biotechnology publishes LML paper on new medical use patents

Nature Biotechnology publishes LML paper on new medical use patents

10 November 2021

‘Mapping the European Patent Landscape for Medical Uses of Known Products’ , co-authored by Prof. Mateo Aboy, Prof. Kathy Liddell, Dr John Liddicoat, Dr Cristina Crespo, and Matt Jordan, uses EPO data to examine the European patent landscape of first and further medical uses of known products. Specifically, the paper...


Read more at: Stevie Martin awarded Yorke Prize

Stevie Martin awarded Yorke Prize

4 November 2021

Dr Stevie Martin has been awarded the Yorke Prize for her doctoral thesis entitled ' Assisted Suicide and the European Convention on Human Rights' , which was published by Routledge earlier this year. The Yorke Prize was endowed in 1873 by Edmund Yorke, Scholar and Fellow of St Catharine’s College, and it is awarded...


Read more at: Tickets still available for CeBIL Symposium 2021 - Orphan Drug Innovation: Needs and Priorities

Tickets still available for CeBIL Symposium 2021 - Orphan Drug Innovation: Needs and Priorities

6 September 2021

Tickets are still available to attend the CeBIL Annual Symposium 2021 - Orphan Drug Innovation: Needs and Priorities. Rare diseases affect approximately 25-30 million people in Europe, including millions of children. However, since each disease affects less than one person in every 2,000, the pharmaceutical industry has...


Read more at: Nature Biotechnology accepts paper from LML on new medical use patents

Nature Biotechnology accepts paper from LML on new medical use patents

2 September 2021

Nature Biotechnology has accepted a seventh article from LML’s empirical-based IP research group. Most countries active in pharmaceutical innovation offer patent protection and market exclusivity for new medical uses of known products. However, the question of whether such policies offer sustainable business models is an...


Read more at: LML published in International Review of Intellectual Property and Competition Law

LML published in International Review of Intellectual Property and Competition Law

20 July 2021

LML is pleased to announce that International Review of Intellectual Property and Competition Law has published 'Has the EU Incentive for Drug Repositioning Been Effective? An Empirical Analysis of the ‘‘+1’’ Regulatory Exclusivity' by John Liddicoat, Kathy Liddell, Mateo Aboy, and Jakob Wested. This paper forms part of...